Kabra Drugs Ltd

Wed 14/10/2026,16:1:0 | BSE : KABRADG

₹18.290.26 (1.44%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 18.44

Previous Close

₹ 18.03

Volume

105034

Mkt Cap ( ₹ Cr)

₹ 43.36

High

₹ 18.44

Low

₹ 17.90

52 Week High

₹ 35.52

52 Week Low

₹ 17.01

Book Value Per Share

₹ 13.39

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Kabra Drugs Ltd

Your Vote -

Buy

33.33%

Hold

0.00%

Sell

66.67%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Kabra Drugs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Kabra Drugs has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    13 Oct 2026, 7:12PM As of September 2026, 100.00% owned by Public. <p align=justify>

  • Kabra Drugs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    12 Oct 2026, 5:06PM Certificate pursuant to Regulation 74 (5) of SEBI regulation, 2018.

  • Kabra Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 4:13PM Scrutinizers Report

  • Kabra Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 4:13PM Scrutinizers Report

  • Kabra Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 4:13PM Scrutinizers Report

  • Kabra Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 4:13PM Scrutinizers Report

  • Kabra Drugs - Shareholder Meeting / Postal Ballot-Outcome of AGM

    30 Sep 2026, 9:38AM Proceedings of Annual General Meeting

  • Kabra Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 4:13PM Scrutinizers Report

  • Kabra Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 4:13PM Scrutinizers Report

  • Kabra Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 4:13PM Scrutinizers Report

  • Kabra Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 4:13PM Scrutinizers Report

  • Kabra Drugs - Reg. 34 (1) Annual Report.

    8 Sep 2026, 7:16PM Reg. 34 (1) of Annual Report for the financial year 2025-2026

  • Kabra Drugs - Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of Indi

    7 Sep 2026, 6:44PM Notice 37th Annual General Meeting of the Company

  • Kabra Drugs - Book Closure And Schedule Of Events For E-Voting.

    3 Sep 2026, 5:11PM Book Closure and schedule of events for E-voting

  • Kabra Drugs - Appointment Of Internal Auditor Of The Company

    2 Sep 2026, 6:49PM Appointment of Internal Auditor of the Company

  • Kabra Drugs - Appointment Of Secretarial Auditor Of The Company

    2 Sep 2026, 6:47PM Appointment of Secretarial Auditor of the Company

  • Kabra Drugs - Board Meeting Outcome for Outcome Of Board Meeting Held On 02Nd September 2026

    2 Sep 2026, 6:38PM Outcome of Board Meeting held on 02nd September 2026

  • Kabra Drugs - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

    29 Aug 2026, 5:03PM Intimation regarding change in resgistered Office of the Company

  • Kabra Drugs - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 02Nd September 2026

    27 Aug 2026, 2:13PM Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and appr

  • Kabra Drugs - Reconstitution Of The Composition Of The Board & Committees Of Regulation 30 Of SEBI (LODR) Regulations, 2015

    18 Aug 2026, 6:27PM Reconstitution of the Composition of the Board & Committees of Regulation 30 of SEBI (LODR) Regulations, 2015

  • Kabra Drugs - Announcement under Regulation 30 (LODR)-Resignation of Director

    12 Aug 2026, 7:50PM Resignation of director of Ms. Anand Anitha

  • Kabra Drugs - Undertaking For Non- Applicability Of Regulation 32 Of SEBI

    12 Aug 2026, 7:28PM Undertaking for Non-Applicability of Reg 32

  • Kabra Drugs - Financial Results For The Quarter Ended 30Th June 2026

    12 Aug 2026, 7:06PM Financials results

  • Kabra Drugs - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2026

    12 Aug 2026, 6:58PM Outcome of Board Meeting held on 12th August 2026

  • Kabra Drugs - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12-August-2026

    5 Aug 2026, 5:25PM Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and appr

  • Kabra Drugs has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    20 Jul 2026, 7:50PM As of June 2026, 100.00% owned by Public. <p align=justify>
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Kabra Drugs Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 30.0436 25.0921 2.7913 0.6508 0.6326
Liabilities 30.0436 25.0921 2.7913 0.6508 0.6326
Equity 23.7079 23.7079 4.3886 4.3886 4.3886
Gross Profit 5.3291 -1.718 -0.736 -0.3442 -0.1754
Net Profit 4.9598 -1.0856 -0.736 -0.3379 -0.1853
Cash From Operating Activities -9.4609 -4.7068 -0.2085 -0.3544 -0.1338
NPM(%) 5.34 0 0 0 0
Revenue 92.74 0 0 0 0
Expenses 87.4109 1.718 0.736 0.3442 0.1754
ROE(%) 15.62 -3.42 -2.31 -1.06 -0.58

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Kabra Drugs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 803.95 -0.30 20.39 10.35 -26.19 0.62
Lotus Eye Hospital and Institute Ltd 109.60 1.11 1597.86 37.70 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 9.50 0.00 0.00 78.29 -39.50 0.00
Astec Lifesciences Ltd 721.00 -0.80 0.00 40.40 -363.14 0.00

Company Info

The company Kabra Drugs Ltd was originally incorporated as Pvt. Ltd company on 22.8.1989 and was subsequently converted into a Public Ltd Company on 1.04.1992. The company is coming out with a public issue on 03.03.93 to part finance the expansion project to manufacture pharmaceutical formulations being set up. The first phase of the project i.e,Ether section has already commenced commercial production. The implementation of second phase involving manufacture of injectables is nearing compoletion and the commercial production is likely to be commenced by June 1993. The implementation of the third and last phase has also started. 2014 -Kabra Drugs appointed M/s. M. Maheshwari & Associates, Practicing Company Secretary for Secretarial Audit.

The company Kabra Drugs Ltd was originally incorporated as Pvt. Ltd company on 22.8.1989 and was subsequently converted into a Public Ltd Company on 1.04.1992. The company is coming out with a public issue on 03.03.93 to part finance the expansion project to manufacture pharmaceutical formulations being set up. The first phase of the project i.e,Ether section has already commenced commercial production. The implementation of second phase involving manufacture of injectables is nearing compoletion and the commercial production is likely to be commenced by June 1993. The implementation of the third and last phase has also started. 2014 -Kabra Drugs appointed M/s. M. Maheshwari & Associates, Practicing Company Secretary for Secretarial Audit.

Parent Organisation

Kabra Drugs Ltd.

Founded

22/08/1989

Managing Director

Mr.N Aravind

NSE Symbol

FAQ